Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Clinical trial NCT01561924 · COMPLETED

Trial details

NCT number: NCT01561924
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A With Inhibitors Haemophilia B With Inhibitors

Start date: 2005-11-01
Primary completion: 2006-05-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.